NuGen Medical Devices Inc. (TSXV:NGMD)
Canada · Delayed Price · Currency is CAD 0.0150
0.00 (0.00%)
Jul 29, 2026, 12:14 PM EST
NuGen Medical Devices Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1.78 | 3.14 | 6.95 | 0.46 | 0.13 | 1.75 |
Cash & Short-Term Investments | 1.78 | 3.14 | 6.95 | 0.46 | 0.13 | 1.75 |
Cash Growth | -71.26% | -54.84% | 1395.51% | 253.33% | -92.49% | 556.92% |
Accounts Receivable | 0.06 | 0.05 | 0.1 | 0.02 | 0.01 | 0.01 |
Other Receivables | 0.11 | 0.06 | 0.23 | 0.33 | 0.24 | 0.3 |
Receivables | 0.17 | 0.12 | 0.33 | 0.36 | 0.24 | 0.31 |
Inventory | 0.5 | 0.5 | 0.32 | 0.21 | 0.08 | 0.01 |
Prepaid Expenses | 0.16 | 0.19 | 0.15 | 0.25 | 0.12 | 0.07 |
Restricted Cash | - | 0.05 | 0.05 | 0.05 | - | - |
Total Current Assets | 2.6 | 3.99 | 7.8 | 1.33 | 0.57 | 2.15 |
Property, Plant & Equipment | 0.58 | 0.3 | 0.01 | 0.03 | 0.16 | 0.02 |
Goodwill | - | - | 1.73 | 1.69 | 1.67 | 1.67 |
Other Intangible Assets | - | - | 3.36 | 3.89 | 4.45 | 5.02 |
Total Assets | 3.18 | 4.29 | 12.89 | 6.95 | 6.85 | 8.84 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.52 | 0.52 | 0.67 | 0.97 | 1.44 | 0.88 |
Accrued Expenses | - | - | - | 0.07 | 0.04 | 0.35 |
Current Portion of Long-Term Debt | 3.06 | 2.98 | 0.57 | 2.14 | 0.08 | - |
Current Portion of Leases | - | - | - | 0.03 | 0.12 | - |
Current Income Taxes Payable | 0.05 | 0.05 | 0.01 | 0.03 | - | - |
Current Unearned Revenue | 0.07 | 0.07 | 0.08 | 0.05 | 0.04 | - |
Other Current Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Current Liabilities | 3.7 | 3.63 | 1.34 | 3.29 | 1.73 | 1.23 |
Long-Term Debt | 14.81 | 14.4 | 17.23 | 5.72 | 7.16 | 5.61 |
Long-Term Leases | - | - | - | - | 0.04 | - |
Other Long-Term Liabilities | 0 | - | - | - | 0.18 | 0.35 |
Total Liabilities | 18.51 | 18.03 | 18.57 | 9.01 | 9.11 | 7.19 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 23.3 | 23.3 | 23.22 | 21.36 | 15.07 | 14.19 |
Retained Earnings | -42.45 | -40.83 | -34.37 | -29.3 | -20.61 | -15.81 |
Comprehensive Income & Other | 3.82 | 3.79 | 5.48 | 5.88 | 3.27 | 3.28 |
Shareholders' Equity | -15.33 | -13.74 | -5.67 | -2.06 | -2.26 | 1.66 |
Total Liabilities & Equity | 3.18 | 4.29 | 12.89 | 6.95 | 6.85 | 8.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 17.87 | 17.38 | 17.8 | 7.88 | 7.41 | 5.61 |
Net Cash (Debt) | -16.09 | -14.24 | -10.86 | -7.42 | -7.28 | -3.86 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.07 | -0.06 | -0.05 | -0.04 | -0.08 | -0.06 |
Filing Date Shares Outstanding | 227.04 | 227.04 | 227.04 | 216.43 | 168.79 | 86.01 |
Total Common Shares Outstanding | 227.04 | 227.04 | 225.83 | 199.13 | 96.56 | 86.01 |
Working Capital | -1.1 | 0.36 | 6.47 | -1.96 | -1.16 | 0.91 |
Book Value Per Share | -0.07 | -0.06 | -0.03 | -0.01 | -0.02 | 0.02 |
Tangible Book Value | -15.33 | -13.74 | -10.75 | -7.65 | -8.38 | -5.02 |
Tangible Book Value Per Share | -0.07 | -0.06 | -0.05 | -0.04 | -0.09 | -0.06 |
Machinery | - | 0.36 | 0.03 | 0.02 | 0.02 | 0.04 |